CV9104

BIOLOGICAL2 trials

Sponsors

CureVac

Conditions

Prostate CancerProstate Carcinoma

Phase 1

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

TerminatedNCT01817738

CureVacProstate Cancer

Start: 2012-08-31End: 2017-01-31Updated: 2017-02-17

Phase 2

An Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate Cancer

TerminatedNCT02140138

CureVacProstate Carcinoma

Start: 2014-06-30End: 2016-04-30Updated: 2016-06-13